@imback
From some rudimentary research, it looks like Pluristem's patents are limited to cells derived from placental or adipose tissue, so MSB won't be infringing by deploying 3D bioreactors for our bone marrow derived cells. Pluristem could still be infringing MSB's patents.
Here's an article about their initial purchase of the "innovative stem cell production technology... The technology covered under the agreement pertains to a three dimensional (3-D) bioreactor system known as PluriX™"
https://www.businesswire.com/news/home/20070522005629/en/Pluristem-Acquires-Patents-Technology-Dimensional-Expansion-Human
Pluristem's US patents can be found here: https://patents.justia.com/search?q=pluristem
Analysis of the EAP, page-407
-
- There are more pages in this discussion • 664 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |